NEW YORK, NY / ACCESS Newswire / January 29, 2025 / If you suffered a loss on your MGP Ingredients, Inc. (NASDAQ:MGPI) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/mgp-ingredients-inc-lawsuit-submission-form?prid=125893&wire=1 or contact Joseph E. Levi, Esq. via email at jlevi@levikorsinsky.com or […]

(NYSE:SPNT), HAMILTON, Bermuda, Jan. 29, 2025 (GLOBE NEWSWIRE) — SiriusPoint Ltd. (“SiriusPoint” or the “Company”) (NYSE: SPNT), a global specialty insurer and reinsurer, has today announced that the Audit Committee of the Board of Directors of SiriusPoint Ltd. has approved a quarterly cash dividend of $0.50 per share on its 8.00% Resettable Fixed Rate Preference

NEW YORK, NY / ACCESS Newswire / January 29, 2025 / If you suffered a loss on your Micron Technology, Inc. (NASDAQ:MU) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/micron-technology-inc-lawsuit-submission-form?prid=125899&wire=1 or contact Joseph E. Levi, Esq. via email at jlevi@levikorsinsky.com or

DORADO, PUERTO RICO / ACCESS Newswire / January 29, 2025 / Pharma-Bio Serv, Inc. ("Pharma-Bio Serv" or the "Company") (OTCQB:PBSV), a regulatory affairs, quality, compliance, project management and technology transfer support consulting firm that provides services to the pharmaceutical, biotechnology, medical device, cosmetic, food and allied products industries, today announced that the Board of Directors

NEW YORK, NY / ACCESS Newswire / January 29, 2025 / If you suffered a loss on your ASP Isotopes Inc. (NASDAQ:ASPI) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/asp-isotopes-inc-lawsuit-submission-form?prid=125900&wire=1 or contact Joseph E. Levi, Esq. via email at jlevi@levikorsinsky.com or

NEW YORK, NY / ACCESS Newswire / January 29, 2025 / If you suffered a loss on your Novo Nordisk A/S (NYSE:NVO) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/novo-nordisk-a-s-lawsuit-submission-form?prid=125897&wire=1 or contact Joseph E. Levi, Esq. via email at jlevi@levikorsinsky.com or

NEW YORK, NY / ACCESS Newswire / January 29, 2025 / If you suffered a loss on your AstraZeneca PLC (NASDAQ:AZN) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/astrazeneca-plc-lawsuit-submission-form?prid=125894&wire=1 or contact Joseph E. Levi, Esq. via email at jlevi@levikorsinsky.com or call

NEW YORK CITY, NY / ACCESS Newswire / January 29, 2025 / Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of Huntington Ingalls Industries, Inc. ("Huntington Ingalls" or "the Company") (NYSE:HII). Investors who purchased Huntington Ingalls securities are encouraged to obtain additional information and assist the investigation by visiting the

Dolby Laboratories, Inc. (NYSE:DLB) today announced the company's financial results for the first quarter of fiscal 2025. https://mma.prnewswire.com/media/2561044/Dolby_Logo.jpg “We are off to a strong start for FY25,” said Kevin Yeaman, President and CEO, Dolby Laboratories. “In Q1, Dolby Atmos and Dolby Vision momentum continued across device categories. At CES, many of our device partners announced

CPC (Colder Products Company), part of Dover(NYSE: DOV) and a leading manufacturer of connection technologies used in biopharmaceutical processing, today announced the launch of its new MicroCNX® Nano Series aseptic connectors, designed to significantly simplify cell and gene therapy (CGT) closed sterile processing. https://mma.prnewswire.com/media/717019/Dover_blue_Logo.jpg “Cell and gene therapy is advancing quickly, but the industry relies